Georgia BioEd Completes Inaugural Rural Teacher Training Initiative

The Georgia BioEd Institute, together with Georgia Youth Science and Technology Centers and the Georgia Department of Education, hosted the inaugural Rural Teacher Training Initiative (RTTI) at UGA’s Griffin Campus on January 13 th and 14 th , 2020.

Seventy-two science teachers in 7th through 12th grade representing 40 Georgia school districts participated. More than 10,000 students in rural Georgia communities stand to benefit. The curriculum for the two-day symposium is based on Georgia life science industry needs and is aligned with Georgia Standards of Excellence as well as the Technical College System of Georgia’s biotechnology programs. Educators practiced new, hands-on, biotech laboratory activities to take back to their classrooms. They connected with industry leaders and recruiters while also collecting contributed laboratory equipment from our industry partners.

Georgia BioEd Rural Teacher Training Initiative (RTTI) participants

The GaBioEd Institute will deliver the balance of all materials necessary to implement the hands-on lab activities to the participant educators. Teachers are now part of an ongoing learning community that regularly meets with their cohort and master instructor throughout the school year for continued support.

“Hands-on teaching takes practice, courage, preparation, and resources,” said RTTI Director Kristin Boscan. “Our goal is to eliminate obstacles to life science education and careers through training, support and equipment supplementation.”

Georgia BioEd Rural Teacher Training Initiative (RTTI) participants

The symposium included an “industry fair” to inform educators about the life science industry in their own backyard, better equipping them to inspire and direct students to successful and frequently lucrative life science careers. The industry fair will certainly foster relationships that lead to industry tours, school field trips and internships.

“You can’t strive towards what you don’t know about,” said Ayesha Okaiwele, a science teacher in the Houston County School System. “When students hear the phrase ‘agriculture careers’ they often think that means farming and becoming a farmer. When, in fact, there’s the technical side of agriculture which involves laboratory work.”

Georgia BioEd Rural Teacher Training Initiative (RTTI) participants

Georgia’s life science industry experienced a 14.9 percent growth in employment from 2007 to 2017, according to the 2019 Georgia Life Sciences State of the Industry Report. Maria Saporta further wrote for the Atlanta Business Chronicle, “The report identified 1,960 unique life science establishments that contributed 68,300 jobs and $10 billion to Georgia’s gross domestic product. When including the multiplier effects, the industry supports a total of about 194,000 jobs, and it contributes $21.8 billion to Georgia’s GDP.”

However, researchers at Georgia Tech found just 4.6 percent of Georgia high schools offer the full biotechnology pathway. They also found that less than one half of one percent of Georgia’s 12th grade students completed the final course in that pathway. This demonstrates a clear need for additional education and workforce development.

In addition to financial and in-kind funding from life science companies in Georgia, the state allocated $323,000 in 2019 for the inaugural program including lab implementation and ongoing support. Georgia BioEd is working to secure state funding during the 2020 legislative session to ensure the program continues on an annual basis.

Georgia BioEd Rural Teacher Training Initiative (RTTI) participants

“The best thing we can do here in Georgia is to create an ecosystem that continues to allow for a growing economy, a talented workforce and significant potential in front of it,” Lt. Governor David Duncan told Georgia Bio last year.

Interested educators can subscribe to the RTTI outreach list and monthly newsletter by emailing mheaphy@gabio.org

“We are grateful to our board members, industry supporters and state leaders for providing the support needed to ensure Georgia can generate the future workforce for the state’s $21 billion life science industry,” Boscan said.

Georgia BioEd Rural Teacher Training Initiative (RTTI) participants

Georgia Bio expresses our gratitude to the following state legislative leadership for helping to make this valuable initiative real to the benefit of all Georgians: Governor Brian Kemp, Lt. Governor Geoff Duncan, House Appropriations Chairman Terry England, Senate Appropriations Chairman Jack Hill, House Appropriations Education Subcommittee Chairman Robert Dickey, Senate Appropriations Education Subcommittee Chairman Ellis Black, Senate Agriculture Chairman John Wilkinson, and House Ethics Chairman Randy Nix.

***

Georgia Bio and the Georgia BioEd Institute would like to thank supporters of the inaugural RTTI Program.

Champions

  • Accenture
  • Annette and Denny Ivey
  • Avantor/VWR  
  • BioRad
  • Dendreon
  • Lab Design and Supply
  • MedShare
  • Sorbtech
  • Takeda
  • The Pipette Solution
  • ThermoFisher
  • Waypoint Analytical

Key Supporters

  • Beate Lloyd
  • Boehringer-Ingelheim
  • Cell Manufacturing Technologies
  • Emory University
  • Georgia Association of Water Professionals
  • Georgia Department of Agriculture
  • Georgia Department of Education
  • Georgia Poultry Laboratory Network
  • Georgia Power
  • Georgia State University
  • Georgia Tech
  • Georgia Youth Science and Technology Centers
  • Gerresheimer
  • Global Center for Medical Innovation
  • GSU BioBus
  • Kennesaw State University
  • Morehouse School of Medicine
  • Quest Diagnostics
  • Recro Gainesville
  • TCSG – Athens Tech
  • UGA – Griffin and Young Scholars’ Program
  • UGA’s Bioexpression and Fermentation Facility
Inaugural Rural Teacher Training Initiative (RTTI) participants 2020
By Maria Thacker Goethe October 22, 2025
“Evolving FTC and DOJ policies leave investors and innovators navigating a cautious M&A landscape
October 6, 2025
Atlanta, GA — October 6 — Georgia Life Sciences today announced the launch of Vitals, a new podcast series developed in partnership with Cloudcast Media, a leader in branded podcast production. The series will spotlight the people, ideas, and innovations shaping the future of Georgia’s rapidly growing life sciences sector. Hosted by Georgia Life Sciences’ CEO, Maria Thacker Goethe, Vitals will feature in-depth conversations with scientists, entrepreneurs, investors, educators, policymakers, and patient advocates. Each episode will explore the challenges and opportunities facing Georgia’s life sciences ecosystem—spanning biopharma, medical technology, digital health, and advanced manufacturing. “Vitals gives us a powerful platform to showcase the remarkable work happening within our state,” said Maria Thacker Goethe. “By sharing these stories, we’re highlighting not only groundbreaking science but also the collaboration and talent that make Georgia such a vibrant hub for health innovation.” Cloudcast Media, known for its expertise in storytelling and high-quality podcast production, will bring industry insights and technical support to ensure the series reaches audiences across Georgia and beyond. “We’re proud to partner with Georgia Life Sciences on Vitals,” said Charles Parisi, Founder and CEO of Cloudcast. “This series will elevate the voices of innovators who are advancing science, improving patient outcomes, and building Georgia’s reputation as a global life sciences leader. We are very excited that Cloudcast Atlanta can play a role in supporting Maria and the impactful work of Georgia Life Sciences.” The first episode of Vitals launched today and is available on Apple Podcasts, Spotify, and other major streaming platforms, as well as through the Georgia Life Sciences website.
October 1, 2025
September 30, 2025 WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on Most Favored Nation policies: "For too many years, Americans have subsidized the research and development necessary to bring newer and better medicines to patients around the world. As we saw with defense spending and NATO, the solution is not to weaken a strategically important American industry, but for other countries to pay their fair share. “Today’s announcement in the Oval Office highlights the problems with a drug delivery system where half of the cost of innovative medicines goes to middlemen and distributors, and where the supply chain distorts prices paid by the American people. We support a new framework that addresses the cost of medicines by simplifying the system - and making medicines directly available to patients. “But importing socialist price controls through most-favored nation policies fundamentally does not address the imbalance in international pricing for innovative medicines. MFN will not lower the out-of-pocket prices that most Americans pay for medicines. Even worse, it will jeopardize the entrepreneurial spirit and deter the capital necessary for a vibrant and essential American biotechnology industry to thrive and may cause most harm to small and midsize biotech companies, which are responsible for discovering more than half of all new treatments. “Without these biotech innovators and a free-market system, we risk slower scientific progress, decreased access to new medicines, compromised national security, fewer American jobs and perhaps most tragically, a diminished hope for those suffering with illness and disease. There are much better ways to address this problem than MFN.” ###
MORE POSTS